Efficacy of (+)-lariciresinol to control bacterial growth of Staphylococcus aureus and Escherichia coli O157:H7

16Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

This study was undertaken to assess the antibacterial potential of a polyphenolic compound (+)-lariciresinol isolated from Rubia philippinensis against selected foodborne pathogens Staphylococcus aureus KCTC1621 and Escherichia coli O157:H7. (+)-Lariciresinol at the tested concentrations (250 μg/disk) evoked a significant antibacterial effect as a diameter of inhibition zones (12.1-14.9 mm) with minimum inhibitory concentration (MIC), and minimum bactericidal concentration values of 125-250 and 125-250 μg/mL, respectively. Furthermore, (+)-lariciresinol at MIC showed reduction in bacterial cell viabilities, efflux of potassium (K+) ions and release of 260 nm materials against E. coli O157:H7 and S. aureus KCTC1621. Moreover, deteriorated cell wall morphology of E. coli O157:H7 and S. aureus KCTC1621 cells treated with (+)-lariciresinol at MIC further confirmed its inhibitory effect against the tested pathogens, suggesting it to be an alternative means of antimicrobials.

Cite

CITATION STYLE

APA

Bajpai, V. K., Shukla, S., Paek, W. K., Lim, J., Kumar, P., Kumar, P., & Na, M. K. (2017). Efficacy of (+)-lariciresinol to control bacterial growth of Staphylococcus aureus and Escherichia coli O157:H7. Frontiers in Microbiology, 8(MAY). https://doi.org/10.3389/fmicb.2017.00804

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free